Gene · 6007
RHD: Rh blood group D antigen
11 sourcesgene-search-2026-11-11-0.1.0
Cite this record
ConductScience Library. RHD: Rh blood group D antigen. Genes, record 6007. Release gene-search-2026-11-11-0.1.0, 11 Nov 2026. https://conductscience.org/library/genes/6007
On this page
Gene
Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q02161 | Blood group Rh(D) polypeptide | 417 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents8
Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 61637 | Q02161 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3716 | Q02161 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3716 | Q02161 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 73137 | Q02161 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 176108 | Q02161 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 242072 | Q02161 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 242072 | Q02161 | Espacenet |
| JP 2015516143 A | 2015-06-08 | 242072 | Q02161 | Espacenet |
Drugs4
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action | Source |
|---|---|---|---|---|
| ATOROLIMUMAB | CHEMBL2108258 | Blood group Rh(D) polypeptide other | OTHER | ChEMBL |
| MOROLIMUMAB | CHEMBL2109138 | Blood group Rh(D) polypeptide inhibitor | INHIBITOR | ChEMBL |
| ROLEDUMAB | CHEMBL1743065 | Blood group Rh(D) polypeptide inhibitor | INHIBITOR | ChEMBL |
| ROZROLIMUPAB | CHEMBL2107859 | Blood group Rh(D) polypeptide inhibitor | INHIBITOR | ChEMBL |
Trials1
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted |
|---|---|---|---|
| NCT00718692 | ROZROLIMUPAB | PHASE2 |
Source ClinicalTrials.gov
NIH grants1,059
NIH projects whose papers are about the gene, through NIH's grant-paper links.
| Project | Title | Its papers about the gene | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 32 | 2025 |
| ZICCL002128 | Laboratory Services Section, Department of Transfusion Medicine Core Report | 10 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| ZIABC011387 | Studies of gene fusions in rhabdomyosarcoma | 6 | 2025 |
| P30CA054174 | Mays Cancer Center at UT Health SA | 5 | 2025 |
| R01HG002385 | Long-read sequence and assembly of segmental duplications | 5 | 2025 |
| R01HL135575 | Examination of Initiating Factors that Regulate Red Blood Cell Alloimmunization | 5 | 2025 |
| ZIACL002123 | Molecular Immunohematology in Ethiopian Sub-populations | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
1 to 10 of 1,059Source NIH's project files
See all 1,059 nih grantsPapers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| PMID | Found by | Source |
|---|---|---|
| 42827334 | PubTator, text mining | PubMed |
| 42819096 | PubTator, text mining | PubMed |
| 42802460 | PubTator, text mining | PubMed |
| 42802457 | PubTator, text mining | PubMed |
| 42802454 | PubTator, text mining | PubMed |
| 42795830 | PubTator, text mining | PubMed |
| 42795721 | PubTator, text mining | PubMed |
| 42790939 | PubTator, text mining | PubMed |
| 42788691 | PubTator, text mining | PubMed |
| 42781294 | PubTator, text mining | PubMed |
1 to 10 of 4,511
See all 4,511 papersSources 11
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNone stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GeneNone named. Public domain as US government information
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6007
GET https://conductscience.org/api/genes/v1/6007/grants?page=2